Viewing Study NCT01847703


Ignite Creation Date: 2025-12-24 @ 7:12 PM
Ignite Modification Date: 2026-02-20 @ 1:43 PM
Study NCT ID: NCT01847703
Status: COMPLETED
Last Update Posted: 2018-03-06
First Post: 2013-05-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Robotic Versus Abdominal Surgery for Endometrial Cancer
Sponsor: Karolinska Institutet
Organization:

Study Overview

Official Title: Randomized Trial Comparing Robotic and Abdominal Surgery for High Risk Endometrial Cancer
Status: COMPLETED
Status Verified Date: 2018-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: RASHEC
Brief Summary: This study is intended to explore differences in oncologic and surgical safety between robotic assisted laparoscopy and conventional abdominal surgery for high risk endometrial cancer.
Detailed Description: Hypothesis: Robotic assisted laparoscopy (RAL)is equal in terms of oncologic and surgical safety as conventional abdominal surgery (AS) for high risk endometrial cancer (EC).

Methods: Women with high risk EC (defined as high grade endometrial, clear cell or serous) are randomized to either RAL or AS. Both groups will undergo complete surgical staging (hysterectomy, bilateral salpingoophorectomy, pelvic and paraaortal lymphadenectomy)

Primary endpoint: Number of harvested lymph nodes per station Secondary endpoints: Recurrences up to 3 year after surgery. Lymphatic side-effects, quality of life, cost, surgical morbidity.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: